Frequently Asked Questions on Meningococcal Disease
MetadataShow full item record
Other Language Versions
Meningococcus, or Neisseria meningitidis, is a bacterium that can be carried harmlessly in the human pharynx or may progress to invasive meningococcal disease, manifesting as septicemia or meningitis. While adolescents and young adults have the highest rates of carriage, infants have the highest rate of invasive meningococcal disease, which causes significant morbidity, disability, and mortality. Meningococcus is found worldwide, including in the Americas, with regional variations in the predominant bacterial strains and in the disease burden. Meningococcal disease is preventable by vaccination. The World Health Organization and partners have developed a global road map toward defeating meningitis by 2030. Through this document, the Pan American Health Organization aims to address a range of frequently asked questions on meningococcus, covering the themes of meningococcal disease, vaccination, vaccine safety, programmatic issues, as well as myths and misconceptions around meningococcal disease and vaccines. The aim of this document is to raise awareness and provide a general overview and clearer understanding of meningococcal disease, including its presentations, diagnosis, and prevention. It summarizes current information on the vaccines used to control invasive meningococcal disease, their types, composition, and administration. While this document is aimed primarily at health professionals, the information it contains is relevant to a broader audience.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Sáfadi, Marco A. P.; Valenzuela, María Teresa; Carvalho, Ana Flavia; De Oliveira, Lúcia Helena; Salisbury, David M.; Andrus, Jon Kim (2017-12)[ABSTRACT]. Opportunities for strengthening surveillance of meningococcal disease exist between and within countries in Latin America. In August of 2015, a workshop was convened in the city of São Paulo, Brazil, to address ...
Unknown author (1976)The first Hemispheric meeting on meningococcal meningitis was held in São Paulo and Brasília on 23-28 February 1976. Organized by the Pan American Health Organization in collaboration with the Government of Brazil and other ...
Community acquired pneumonia incidence among children less than 5 years of age in Concordia, Argentina: vaccination impact Ruvinsky, Raúl O.; Rearte, Analía; Kupervaser, Judit; Gentile, Fernando; Haidar, Adriana; Cafure, Maria E.; Tito, Maria Elisa; Avaro, Federico; Cortiana, Cristina; Cozzani, Hugo; Véliz, Omar; Fossati, Sofia; Regueira, Mabel; Vizzotti, Carla (2018-11)[ABSTRACT]. Objective. To measure the effectiveness of pneumococcal conjugated vaccine (PCV13) against Community Acquired Pneumonia (CAP) and invasive pneumococcal disease, 2 years after the vaccine (2+1) was included into ...